Technical Bulletin No. 372 of the U.S. National Library of Medicine (NLM) was posted on January 5, 2010. Excerpt:
Effective mid-October 2009, when a published article has an acknowledgement of funding support from the Canadian Institutes of Health Research (CIHR), that information is added to the PubMed journal citation.
At present, a search using the country name alone (a search on ‘canada [gr]’) retrieves the relevant records, because CIHR is the only Canadian organization in the Grant Number field in PubMed at this time.
Thus, it’s now feasible to obtain, via PubMed, data that will provide indicators of compliance with the Policy on Access to Research Outputs of the CIHR. This policy “applies to all grants awarded January 1, 2008 and onward, which have received funding in whole or in part from CIHR“.
For example, the Advanced Search option in PubMed can be used to obtain an estimate of the total number of CIHR-supported publications with a publication date in the last 2 months of 2009. The result (search #1): 867.
Analogous data can be obtained for several topics (such as ‘Cancer’). Total number of cancer-related (and CIHR-supported) publications with a publication date in the last 2 months of 2009 (search #4): 221. Number of these for which links to ‘free full text’ were available (search #5): 23 (10% of 221). Of these 23 publications, 7 (30%) were published in PLoS ONE (search #6). (The other 16 articles were distributed across 14 different journals).
Comment: As the Policy on Access to Research Outputs of the CIHR is implemented, one can expect to see an increase in the percentage of CIHR-supported publications (cited in PubMed) for which links to ‘free full text’ will be available. As noted in NLM Technical Bulletin No. 372:
A PubMed Central Canada manuscript submission system will be implemented in early 2010. This will be another source for grant information from the Canadian Institutes of Health Research.
(Note: the link to PMC Canada in the current version of NLM Technical Bulletin No. 372 is corrupted).